Central and Eastern Sydney Primary Health Network (CESPHN) is pleased to announce that Leichhardt General Practice is one of 20 clinics nationally that has been selected to provide expert, multidisciplinary services, and care for women with endometriosis and pelvic pain.
Endometriosis affects at least 1 in 9 Australian women and can have an extensive, devastating impact on their daily lives. Women affected by endometriosis wait on average seven years before diagnosis.
Leichhardt General Practice is well-placed to operate this clinic having:
Expertise in women’s health, including provision of diagnosis, treatment and management of endometriosis and pelvic pain,
A deep understanding of and links to the local community, and the
Ability to work closely with other primary and tertiary care services.
Funding of over $700,000 will be provided over 4 years to the Leichhardt General Practice and will support hiring specialised staff, including allied health professionals, investment in equipment or fit-outs such as pelvic physiotherapy areas, as well as resources, training and development. The Leichhardt General Practice will work with other primary care practices to share and enhance knowledge on how best to treat and manage endometriosis and pelvic pain.
This funding will improve access for women to diagnostic, treatment and referral services for endometriosis and pelvic pain, build the primary care workforce to manage this chronic condition and provide improved access to new information and care pathways.
Dr Rebecca South from Leichhardt General Practice said:
“With this funding we have the opportunity to support more women with endometriosis and pelvic pain with early diagnosis and a clear treatment pathway and make a real difference to improving the health and wellbeing of women.”
Central and Eastern Sydney PHN CEO Nathalie Hansen said:
“I’m looking forward to this service making a real difference to the lives of women experiencing endometriosis and pelvic pain and working with the Leichhardt General Practice to grow the knowledge base of primary care professionals working in women’s health.”
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…